Hi Relyts, This may sound like a dumb question but what would this mean for shareholders? Would this be a merger type deal or just a sale of the drug and patent to big Pharma resulting in huge revenue?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.